成人症状性腰椎侧凸的手术与非手术治疗对比
研究纳入9个北美中心的成人症状性腰椎侧凸患者,进行随机或观察性队列比较手术与非手术治疗。随机队列意向性分析2年时两组无差异,但非依从性高(64%非手术组转为手术);按实际治疗分析手术组SRS-22和ODI改善更优,总体应答分析中手术组达到MCID比例更高。结论认为对现状满意者建议非手术,期望改善者手术更优。
要点
- 随机队列意向性分析2年时手术与非手术组结果无差异,但非手术组64%转为手术。
- 按实际治疗分析,手术组SRS-22子评分改善优于非手术组(调整均差0.7,95%CI 0.5-1.0)。
- 手术组ODI改善优于非手术组(调整均差-16,95%CI -22至-10),p<0.001。
核心结论
- 基于按实际治疗和MCID分析,若患者对当前脊柱相关健康满意,建议非手术治疗,但改善可能性小。
- 若患者对当前脊柱健康不满意并期望改善,手术更优。
研究设计与样本
- 研究为同时进行的随机队列或观察性队列,纳入9个北美中心的成人症状性腰椎侧凸患者(40-80岁,冠状Cobb角≥30°,ODI评分≥20或SRS-22评分≤4.0)。
- 随机队列63例(手术组30例,非手术组33例);观察性队列223例(手术组112例,非手术组111例)。
- 主要结局为2年随访时SRS-22子评分和ODI较基线的平均变化差异。
主要发现
- 随机队列意向性分析2年随访时两组结局无差异,非依从性高(非手术组64%转为手术)。
- 随机队列按实际治疗分析,手术组2年时SRS-22子评分改善更大(调整均差0.7,95%CI 0.5-1.0),ODI改善更大(调整均差-16,95%CI -22至-10),均p<0.001。
- 观察性队列2年时手术组SRS-22子评分和ODI结局优于非手术组(p<0.001)。
- 总体应答分析中,手术组达到或超过MCID的比例更高:SRS-22子评分85.7% vs 38.7%(p<0.001),ODI 77.4% vs 38.3%(p<0.001)。
- 手术患者中24例(14%)进行了34次翻修手术。
关键数值与推荐
- 成人症状性腰椎侧凸入组标准:年龄40-80岁,冠状Cobb角≥30°,ODI评分≥20或SRS-22评分≤4.0。
- 随机队列初始样本量计算估计每组41例(共82例)可提供80%把握度,α=0.05,预期10%失访和非手术组20%非依从;中期样本量计算估计每组18例足够。
- 按实际治疗分析中,手术组SRS-22子评分调整均差0.7(95%CI 0.5-1.0),ODI调整均差-16(95%CI -22至-10),均p<0.001。
- 总体应答分析中,手术组达到MCID比例SRS-22子评分85.7% vs 非手术组38.7%(p<0.001),ODI 77.4% vs 38.3%(p<0.001)。
临床怎么用
- 作者结论:若患者对当前脊柱相关健康满意,建议非手术治疗,但需理解改善可能性小。
- 作者结论:若患者对当前脊柱健康不满意并期望改善,手术更优。
局限性
- 随机队列非依从性高(非手术组64%转为手术)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effectiveness of operative compared with nonoperative treatment at initial presentation (no prior fusion) for adult lumbar scoliosis has not, to our knowledge, been evaluated in controlled trials. The goals of this study were to evaluate the effects of operative and nonoperative treatment and to assess the benefits of these treatments to help treating physicians determine whether patients are better managed operatively or nonoperatively. METHODS: Patients with adult symptomatic lumbar scoliosis (aged 40 to 80 years, with a coronal Cobb angle measurement of ≥30° and an Oswestry Disability Index [ODI] score of ≥20 or Scoliosis Research Society [SRS]-22 score of ≤4.0) from 9 North American centers were enrolled in concurrent randomized or observational cohorts to evaluate operative versus nonoperative treatment. The primary outcomes were differences in the mean change from baseline in the SRS-22 subscore and ODI at 2-year follow-up. For the randomized cohort, the initial sample-size calculation estimated that 41 patients per group (82 total) would provide 80% power with alpha equal to 0.05, anticipating 10% loss to follow-up and 20% nonadherence in the nonoperative arm. However, an interim sample-size calculation estimated that 18 patients per group would be sufficient. RESULTS: Sixty-three patients were enrolled in the randomized cohort: 30 in the operative group and 33 in the nonoperative group. Two hundred and twenty-three patients were enrolled in the observational cohort: 112 in the operative group and 111 in the nonoperative group. The intention-to-treat analysis of the randomized cohort found that, at 2 years of follow-up, outcomes did not differ between the groups. Nonadherence was high in the randomized cohort (64% nonoperative-to-operative crossover). In the as-treated analysis of the randomized cohort, operative treatment was associated with greater improvement at the 2-year follow-up in the SRS-22 subscore (adjusted mean difference, 0.7 [95% confidence interval (CI), 0.5 to 1.0]) and in the ODI (adjusted mean difference, -16 [95% CI, -22 to -10]) (p < 0.001 for both). Surgery was also superior to nonoperative care in the observational cohort at 2 years after treatment on the basis of SRS-22 subscore and ODI outcomes (p < 0.001). In an overall responder analysis, more operative patients achieved improvement meeting or exceeding the minimal clinically important difference (MCID) in the SRS-22 subscore (85.7% versus 38.7%; p < 0.001) and the ODI (77.4% versus 38.3%; p < 0.001). Thirty-four revision surgeries were performed in 24 (14%) of the operative patients. CONCLUSIONS: On the basis of as-treated and MCID analyses, if a patient with adult symptomatic lumbar scoliosis is satisfied with current spine-related health, nonoperative treatment is advised, with the understanding that improvement is unlikely. If a patient is not satisfied with current spine health and expects improvement, surgery is preferred. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Kelly MP, Lurie JD, Yanik EL, et al. Operative Versus Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis. J Bone Joint Surg Am. 2019. PMID: 30801373. doi:10.2106/JBJS.18.00483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。